Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $26,818 | 5 | 83.0% |
| Travel and Lodging | $3,986 | 16 | 12.3% |
| Food and Beverage | $1,493 | 22 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eisai Inc. | $14,642 | 22 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $12,129 | 2 | $0 (2019) |
| AbbVie, Inc. | $3,681 | 6 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $1,585 | 10 | $0 (2017) |
| Penumbra, Inc. | $141.49 | 1 | $0 (2022) |
| Intuitive Surgical, Inc. | $118.88 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $260.37 | 3 | Penumbra, Inc. ($141.49) |
| 2021 | $1,800 | 1 | Eisai Inc. ($1,800) |
| 2019 | $19,203 | 11 | Takeda Pharmaceuticals U.S.A., Inc. ($12,000) |
| 2018 | $3,809 | 7 | AbbVie, Inc. ($3,681) |
| 2017 | $7,224 | 21 | Eisai Inc. ($5,639) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2022 | Penumbra, Inc. | RUBY Coil (Device) | Food and Beverage | Cash or cash equivalent | $141.49 | General |
| Category: Peripheral Intervention | ||||||
| 02/11/2022 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $112.88 | General |
| Category: SURGERY | ||||||
| 02/05/2022 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $6.00 | General |
| Category: SURGERY | ||||||
| 03/30/2021 | Eisai Inc. | Dayvigo (Drug) | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| Category: Neurology | ||||||
| 10/29/2019 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $12,000.00 | General |
| 02/22/2019 | Eisai Inc. | — | Consulting Fee | Cash or cash equivalent | $6,225.00 | General |
| 02/22/2019 | Eisai Inc. | — | Travel and Lodging | Cash or cash equivalent | $474.60 | General |
| 02/22/2019 | Eisai Inc. | — | Travel and Lodging | Cash or cash equivalent | $185.95 | General |
| 02/22/2019 | Eisai Inc. | — | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| 02/22/2019 | Eisai Inc. | — | Food and Beverage | Cash or cash equivalent | $60.60 | General |
| 02/22/2019 | Eisai Inc. | — | Food and Beverage | Cash or cash equivalent | $42.94 | General |
| 02/22/2019 | Eisai Inc. | — | Travel and Lodging | Cash or cash equivalent | $36.00 | General |
| 02/22/2019 | Eisai Inc. | — | Food and Beverage | Cash or cash equivalent | $24.99 | General |
| 02/22/2019 | Eisai Inc. | — | Food and Beverage | Cash or cash equivalent | $24.99 | General |
| 02/22/2019 | Eisai Inc. | — | Food and Beverage | Cash or cash equivalent | $3.18 | General |
| 08/06/2018 | AbbVie, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,812.50 | General |
| 08/06/2018 | AbbVie, Inc. | — | Travel and Lodging | In-kind items and services | $200.50 | General |
| 07/24/2018 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $128.69 | General |
| 07/21/2018 | AbbVie, Inc. | — | Travel and Lodging | In-kind items and services | $484.34 | General |
| 07/21/2018 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $84.25 | General |
| 07/21/2018 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $69.27 | General |
| 07/21/2018 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $29.69 | General |
| 08/14/2017 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $97.81 | General |
| Category: Neurology | ||||||
| 06/08/2017 | Novartis Pharmaceuticals Corporation | CNP520 (Drug) | Travel and Lodging | In-kind items and services | $204.75 | General |
| 06/08/2017 | Novartis Pharmaceuticals Corporation | CNP520 (Drug) | Travel and Lodging | Cash or cash equivalent | $107.01 | General |
About James Burke
James Burke is a Neurology healthcare provider based in Durham, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528141769.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, James Burke has received a total of $32,297 in payments from pharmaceutical and medical device companies, with $260.37 received in 2022. These payments were reported across 43 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($26,818).
Practice Information
- Specialty Neurology
- Location Durham, NC
- Active Since 10/23/2006
- Last Updated 03/22/2013
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1528141769
Products in Payments
- Dayvigo (Drug) $1,800
- CNP520 (Drug) $1,064
- RUBY Coil (Device) $141.49
- Da Vinci Surgical System (Device) $118.88
- Fycompa (Drug) $97.81
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Durham
Mark Skeen, M.d, M.D
Neurology — Payments: $770,195
Dr. Kevin Kahn, Md, MD
Neurology — Payments: $662,344
Dr. Alan Finkel, Md, MD
Neurology — Payments: $405,703
Natalia Gonzalez, Md, MD
Neurology — Payments: $219,812
Dr. Anne Calhoun, Md, MD
Neurology — Payments: $203,020
Dr. Jeffrey Guptill, M.d, M.D
Neurology — Payments: $191,526